Howard DH, Bach PB, Berndt ER, et al. Pricing in the market for anticancer drugs. J Econ Perspect 2015;29:139–162.

• Crossref
• PubMed
Howard DH, Bach PB, Berndt ER, Pricing in the market for anticancer drugs. J Econ Perspect 2015;29:139–162.10.1257/jep.29.1.13928441702)| false
• Search Google Scholar
• Export Citation

Soni A. Trends in use and expenditures for cancer treatment among adults 18 and older, US civilian noninstitutionalized population, 2001 and 2011. Accessed June 4, 2020. Available at: https://meps.ahrq.gov/data_files/publications/st443/stat443.shtml

• PubMed
Soni A. Trends in use and expenditures for cancer treatment among adults 18 and older, US civilian noninstitutionalized population, 2001 and 2011. Accessed June 4, 2020. Available at: https://meps.ahrq.gov/data_files/publications/st443/stat443.shtml)| false
• Export Citation

Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 2013;18:381–390.

• Crossref
• PubMed
Zafar SY, Peppercorn JM, Schrag D, The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 2013;18:381–390.10.1634/theoncologist.2012-027923442307)| false
• Search Google Scholar
• Export Citation

Kent EE, Forsythe LP, Yabroff KR, et al. Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care? Cancer 2013;119:3710–3717.

• Crossref
• PubMed
Kent EE, Forsythe LP, Yabroff KR, Are survivors who report cancer‐related financial problems more likely to forgo or delay medical care? Cancer 2013;119:3710–3717.2390795810.1002/cncr.28262)| false
• Search Google Scholar
• Export Citation

Dusetzina SB, Winn AN, Abel GA, et al. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 2014;32:306–311.

• Crossref
• PubMed
Dusetzina SB, Winn AN, Abel GA, Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 2014;32:306–311.2436693610.1200/JCO.2013.52.9123)| false
• Search Google Scholar
• Export Citation

Knight TG, Deal AM, Dusetzina SB, et al. Financial toxicity in adults with cancer: adverse outcomes and noncompliance [published online October 24, 2018]. J Oncol Pract, doi: 10.1200/JOP.18.00120

• PubMed
Knight TG, Deal AM, Dusetzina SB, Financial toxicity in adults with cancer: adverse outcomes and noncompliance [published online October 24, 2018]. J Oncol Pract, doi: 10.1200/JOP.18.00120)| false
• Search Google Scholar
• Export Citation

Zafar SY. Financial toxicity of cancer care: it’s time to intervene. J Natl Cancer Inst 2015;108:djv370

• PubMed
Zafar SY. Financial toxicity of cancer care: it’s time to intervene. J Natl Cancer Inst 2015;108:djv37026657334)| false
• Search Google Scholar
• Export Citation

Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system [pubished online May 1, 2020]. Cancer Discov, doi: 10.1158/2159-8290.CD-20-0516

• PubMed
Mehta V, Goel S, Kabarriti R, Case fatality rate of cancer patients with COVID-19 in a New York hospital system [pubished online May 1, 2020]. Cancer Discov, doi: 10.1158/2159-8290.CD-20-0516)| false
• Search Google Scholar
• Export Citation

Unemployment Insurance Weekly Claims May 16, 2020 [Internet]. Washington, DC: United States Department of Labor; 2020. Accessed May 16, 2020. Available at: https://oui.doleta.gov/unemploy/claims.asp

• PubMed
Unemployment Insurance Weekly Claims May 16, 2020 [Internet]. Washington, DC: United States Department of Labor; 2020. Accessed May 16, 2020. Available at: https://oui.doleta.gov/unemploy/claims.asp)| false
• Export Citation

Khera N, Sugalski J, Krause D, et al. Current practices for screening and management of financial distress at NCCN Member Institutions. J Natl Compr Canc Netw 2020;18:825–831.

• Crossref
• PubMed
Khera N, Sugalski J, Krause D, Current practices for screening and management of financial distress at NCCN Member Institutions. J Natl Compr Canc Netw 2020;18:825–831.10.6004/jnccn.2020.753832634772)| false
• Search Google Scholar
• Export Citation

Khera N, Holland JC, Griffin JM. Setting the stage for universal financial distress screening in routine cancer care. Cancer 2017;123:4092–4096.

• Crossref
• PubMed
Khera N, Holland JC, Griffin JM. Setting the stage for universal financial distress screening in routine cancer care. Cancer 2017;123:4092–4096.2881718510.1002/cncr.30940)| false
• Search Google Scholar
• Export Citation

Shankaran V, Leahy T, Steelquist J, et al. Pilot feasibility study of an oncology financial navigation program. J Oncol Pract 2018;14:e122–129.

• Crossref
• PubMed
Shankaran V, Leahy T, Steelquist J, Pilot feasibility study of an oncology financial navigation program. J Oncol Pract 2018;14:e122–129.10.1200/JOP.2017.02492729272200)| false
• Search Google Scholar
• Export Citation

de Souza JA, Yap BJ, Wroblewski K et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 2017;123:476–484.

• Crossref
• PubMed
de Souza JA, Yap BJ, Wroblewski K Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 2017;123:476–484.10.1002/cncr.30369)| false
• Search Google Scholar
• Export Citation